379 related articles for article (PubMed ID: 26711021)
21. Antigenic Evolution Characteristics and Immunological Evaluation of H9N2 Avian Influenza Viruses from 1994-2019 in China.
Liu Q; Zhao L; Guo Y; Zhao Y; Li Y; Chen N; Lu Y; Yu M; Deng L; Ping J
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458455
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
23. Genotypic evolution and epidemiological characteristics of H9N2 influenza virus in Shandong Province, China.
Li Y; Liu M; Sun Q; Zhang H; Zhang H; Jiang S; Liu S; Huang Y
Poult Sci; 2019 Sep; 98(9):3488-3495. PubMed ID: 30941436
[TBL] [Abstract][Full Text] [Related]
24. Continuing evolution of H9 influenza viruses in Korean poultry.
Lee YJ; Shin JY; Song MS; Lee YM; Choi JG; Lee EK; Jeong OM; Sung HW; Kim JH; Kwon YK; Kwon JH; Kim CJ; Webby RJ; Webster RG; Choi YK
Virology; 2007 Mar; 359(2):313-23. PubMed ID: 17056087
[TBL] [Abstract][Full Text] [Related]
25. The emergence of new antigen branches of H9N2 avian influenza virus in China due to antigenic drift on hemagglutinin through antibody escape at immunodominant sites.
Zhang N; Quan K; Chen Z; Hu Q; Nie M; Xu N; Gao R; Wang X; Qin T; Chen S; Peng D; Liu X
Emerg Microbes Infect; 2023 Dec; 12(2):2246582. PubMed ID: 37550992
[TBL] [Abstract][Full Text] [Related]
26. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
[No Abstract] [Full Text] [Related]
27. [Genetic mutations of heamagglutinin genes of H9N2 subtype influenza A viruses in the field in a five-year period].
Liu H; Zhang P; Liu X; Liu W; Jia L
Wei Sheng Wu Xue Bao; 2003 Dec; 43(6):706-11. PubMed ID: 16276889
[TBL] [Abstract][Full Text] [Related]
28. Antigenic Cartography of H9 Avian Influenza Virus and Its Application to Vaccine Selection.
Wang Y; Davidson I; Fouchier R; Spackman E
Avian Dis; 2016 May; 60(1 Suppl):218-25. PubMed ID: 27309058
[TBL] [Abstract][Full Text] [Related]
29. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
[TBL] [Abstract][Full Text] [Related]
30. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.
Song JM; Lee YJ; Jeong OM; Kang HM; Kim HR; Kwon JH; Kim JH; Seong BL; Kim YJ
Vet Microbiol; 2008 Aug; 130(3-4):268-76. PubMed ID: 18374520
[TBL] [Abstract][Full Text] [Related]
31. Phylogenetic classification of hemagglutinin gene of H9N2 avian influenza viruses isolated in China during 2012-2016 and evaluation of selected candidate vaccine strains.
Xu C; Ye H; Qiu W; Lin H; Chen Y; Zhang H; Liao M
Poult Sci; 2018 Sep; 97(9):3023-3030. PubMed ID: 29931183
[TBL] [Abstract][Full Text] [Related]
32. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
Song H; Nieto GR; Perez DR
J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
[TBL] [Abstract][Full Text] [Related]
33. The antigenic drift molecular basis of the H5N1 influenza viruses in a novel branch of clade 2.3.4.
Zhong L; Zhao Q; Zhao K; Wang X; Zhao G; Li Q; Gu M; Peng D; Liu X
Vet Microbiol; 2014 Jun; 171(1-2):23-30. PubMed ID: 24745625
[TBL] [Abstract][Full Text] [Related]
34. HA gene amino acid mutations contribute to antigenic variation and immune escape of H9N2 influenza virus.
Zhu R; Xu S; Sun W; Li Q; Wang S; Shi H; Liu X
Vet Res; 2022 Jun; 53(1):43. PubMed ID: 35706014
[TBL] [Abstract][Full Text] [Related]
35. Phylogenetic Analysis of Hemagglutinin Genes of H9N2 Avian Influenza Viruses Isolated from Chickens in Shandong, China, between 1998 and 2013.
Zhao Y; Li S; Zhou Y; Song W; Tang Y; Pang Q; Miao Z
Biomed Res Int; 2015; 2015():267520. PubMed ID: 26609523
[TBL] [Abstract][Full Text] [Related]
36. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
37. Antigenic structure of the hemagglutinin of H9N2 influenza viruses.
Okamatsu M; Sakoda Y; Kishida N; Isoda N; Kida H
Arch Virol; 2008; 153(12):2189-95. PubMed ID: 18989614
[TBL] [Abstract][Full Text] [Related]
38. Development of blocking ELISA for detection of antibodies against H9N2 avian influenza viruses.
Yang J; Dai X; Chen H; Teng Q; Li X; Rong G; Yan L; Liu Q; Li Z
J Virol Methods; 2016 Mar; 229():40-7. PubMed ID: 26724274
[TBL] [Abstract][Full Text] [Related]
39. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
